TEST TWO,CHOOSE ONE SUMMARY

IDEA MeOmics uses Precision Psychiatry Platform to improve and personalize mental health treatments.

STRATEGY Disruption Strategy STRATEGY ARCHITECTURAL STRATEGY

TRADE OFFS TECHNOLOGY CUSTOMER TECHNOLOGY CUSTOMER TRADE OFFS

Utilizes cutting-edge
AI and Med Tech companies,
biotechnological assays conversion of blood samples into
pharmaceutical companies, Patients, Healthcare
combined with genomics to stem cells, which are then
healthcare providers within the providers, and Researchers
provide personalized treatment transformed into neural networks
mental health space
plans

COMPETITION ORGANISATION COMPETITION ORGANISATION

Will have to dichotomy
compete with Incumbent pharmaceutical companies Leverages the founders' academic research unique focus on mental health broader ecosystem of
and biotech start-ups. and their expertise in psychiatric genomics between
through precision psychiatry could healthcare providers, research
other incumbents Differentiate through unique focus on and stem cell biology. Internal capabilities
include ability to handle large volumes of differentiate them and provide a institutions, and potential
mental health through precision competitive edge. modularity and
instead of psychiatry and provide a competitive complex multimodal data. commercial partners
edge. integration.
collaborating
create a predictive tool for mental health VALUE CREATION facilitating a more integrated
VALUE CREATION
treatment that creates more value for patients
HYPOTHESIS and healthcare providers HYPOTHESIS approach to patient care.

service fee and a data platform used by entities licensing agreements, service fees, and
VALUE CAPTURE VALUE CAPTURE
like pharmaceutical companies, for drug subscription-based access to its database
HYPOTHESIS development HYPOTHESIS and analytics tools

EXPERIMENTATION EXPERIMENTATION

By focusing on an underserved area of mental health care and
employing a novel technological approach, MeOmics disrupts the
traditional methods of mental health treatment and drug
development.
MeOmics leverages the architectural strategy to align its resources,
capabilities, and market opportunities to create significant value in the mental
health sector. The venture's focus on innovative technology, strategic
partnerships, and a clear, scalable business model positions it well for success
in the global mental healthcare market.